TRYAL

Executive Summary

TRYAL is a digital health company founded in 2018 and headquartered in San Francisco, focused on transforming clinical trial operations by prioritizing the human experience and wrapping advanced technology around existing processes. The company aims to address the everyday challenges that delay trials and overwhelm study teams, leveraging the expertise of industry veterans. While specific financial details, stage, and total funding are undisclosed, TRYAL's positioning in the clinical trial software space aligns with growing demand for decentralized and patient-centric trial solutions. The company's approach could differentiate it in a crowded market, but the lack of publicly available milestones or revenue data limits assessable traction.

Upcoming Catalysts (preview)

• Q3 2026Series A Funding Announcement50% success
• Q4 2026Major Partnership with Pharma or CRO40% success
• Q3 2026Product Launch or Platform Upgrade60% success